Meningococcal ACWY Conjugate Vaccine (MenACWY) 2021- 2023 (2023- 2024, 2024-2025)

Hange

03 - Contract award notice
Avatud menetlus
22.09.2021 10:24 (GMT+03:00)

Hankija

Terveyden ja hyvinvoinnin laitos Terveyden ja hyvinvoinnin laitos
Tuija Orre Finnish Institute for Healh and Welfare (THL)
PL 30
00271 Helsinki
Finland
2229500-6

Eesmärk

The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the medical risk groups.

Mercell Estonia OÜ

Mercelli gruppi kuuluv Euroopa juhtiv e-hanke keskkond vahendab infot ostjate ja tarnijate vahel.

Kontakt

Mercell Eesti kasutajatugi

+372 683 6785
Mercell Estonia OÜ | Põhja puiestee 21C, 10143 Tallinn, Eesti